These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3906759)

  • 1. Sensitivity and specificity of cerebrospinal fluid biochemical markers of central nervous system metastases.
    Ongerboer de Visser BW; van Zanten AP; Twijnstra A; Nooyen WJ; Hart AA
    Prog Exp Tumor Res; 1985; 29():105-15. PubMed ID: 3906759
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid biochemical markers of central nervous system metastases.
    Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
    Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
    Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
    J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer.
    Dearnaley DP; Patel S; Powles TJ; Coombes RC
    Oncodev Biol Med; 1981; 2(4):305-11. PubMed ID: 7301610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of tumor markers in cerebrospinal fluid.
    Jaeckle KA
    Clin Lab Med; 1985 Jun; 5(2):303-15. PubMed ID: 2411459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.
    Twijnstra A; van Zanten AP; Nooyen WJ; Ongerboer de Visser BW
    J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1246-50. PubMed ID: 3540216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases.
    van Zanten AP; Twijnstra A; van Benthem V; Hart AA; Ongerboer de Visser BW
    Clin Chim Acta; 1985 Apr; 147(2):127-34. PubMed ID: 3987058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid biochemical markers in central nervous system tumors: a review.
    Wasserstrom WR; Schwartz MK; Fleisher M; Posner JB
    Ann Clin Lab Sci; 1981; 11(3):239-51. PubMed ID: 6166240
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta 2-microglobulin and tumors of the central nervous system].
    Hrazdirová V; Hrazdira CL; Polcáková M
    Cesk Neurol Neurochir; 1990 Jan; 53(1):17-21. PubMed ID: 2185897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cerebrospinal fluid concentrations of beta-glucuronidase and beta 2-microglobulin in neurological disorders].
    Oda R; Hirose G; Emori T
    No To Shinkei; 1985 Feb; 37(2):155-60. PubMed ID: 3890905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
    Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
    Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A correlative study of cytology and carcinoembryonic antigen determination in cerebrospinal fluid in the diagnosis of breast cancer cerebro-meningeal metastases (author's transl)].
    Fontaniere B; Ardiet C; Clavel M; Lahneche B; Clavel E; Faucon M
    Arch Anat Cytol Pathol; 1981; 29(5):287-90. PubMed ID: 7305463
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.
    Jacobi C; Reiber H; Felgenhauer K
    J Neurol; 1986 Nov; 233(6):358-61. PubMed ID: 3806144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases.
    Twijnstra A; Nooyen WJ; van Zanten AP; Hart AA; Ongerboer de Visser BW
    Arch Neurol; 1986 Mar; 43(3):269-72. PubMed ID: 3947276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
    Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
    Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in cerebrospinal fluid--its diagnostic value in neoplasms of the central nervous system.
    Yoshida M; Ohshima Y; Moritaka K; Kuramoto S
    Kurume Med J; 1984; 31(2):73-9. PubMed ID: 6521423
    [No Abstract]   [Full Text] [Related]  

  • 19. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
    Wasserstrom WR; Glass JP; Posner JB
    Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.